Aaron Schacht | Executive Vice President - Innovation, Regulatory And Business Development
Elanco Animal Health | United States

Aaron Schacht, Executive Vice President - Innovation, Regulatory And Business Development, Elanco Animal Health

Aaron Schacht serves as executive vice president, Innovation, Regulatory, and Business Development at Elanco. In this role, he oversees global R&D, regulatory, business development and nutritional health. With a focus on ideas, products and technologies that address customers’ unmet needs, he applies his passion for scientific discovery to pursue innovative animal health solutions. Schacht and his team collaborate with scientists, animal caretakers, and pharmaceutical product developers to enhance health and longevity for pets and food animals.Schact began his career in R&D more than 25 years ago brings expertise in health care innovation to this position. Prior to this, he served as global brand development leader of pain in Eli Lilly & Company BioMedicines.In his tenure with Eli Lilly and Company, Schact has been an integral member of leadership, serving in roles that include senior advisor of strategy & business development for Lilly BioMedicines, executive director of global external R&D at Lilly, executive director of Lilly Research Labs strategy, portfolio management and project management and director of the Innovation Center in the eLilly organization. He began his career at Lilly in 1990 as medicinal chemist working to discover pharmaceuticals to treat cardiovascular disorders. Schacht studied organic chemistry at the University of Illinois, receiving his bachelor’s degree in 1990.

Appearances:



Oct 28th Pre-Congress Workshops @ 10:00

Workshop A: Funding & Investment for Animal Health

What investment opportunities are there to support animal and one health efforts in Europe? Attend this workshop to hear from private and public funding bodies, as well as learn from existing industry players in this space to help develop your business.Overview of the current animal health investment landscape; Where are the gaps?Funding veterinary biologics research How to partner with Big Pharma
last published: 19/Sep/19 13:06 GMT

back to speakers

Sign Up for Event Updates